Hikma Pharmaceutical | HIK - Des Atouts

Prix De L'Action
1,372.75
Variation Quotidienne
-29.75 -2.12%
Mensuellement
7.84%
Annuel
-27.71%
Q2 Prévisions
1,355.69




Des Atouts Changement Date
Almirall EUR 2.34B 29.21M 2025-12
argenx SE USD 7.18B 973.07M 2025-06
AstraZeneca USD 114.07B 382M 2025-12
Autolus Therapeutics Ltd USD 589.07M 72.88M 2025-12
Bayer EUR 104.54B 331M 2025-12
Fresenius EUR 42.46B 1.14B 2025-09
Galapagos EUR 3.41B 105.39M 2025-12
Genmab DKK 12.87B 5.85B 2025-12
GlaxoSmithKline GBP 61.12B 221M 2025-12
GRIFOLS EUR 19.71B 141.77M 2025-12
Hikma Pharmaceutical USD 5.67B 117M 2025-12
Lonza CHF 18.97B 164M 2025-12
Merck EUR 51.53B 600M 2025-12
Orion EUR 2.01B 262M 2025-12
Recordati EUR 5.3B 122.58M 2025-09
Roche Holding CHF 100.7B 5.94B 2025-12
Sanofi EUR 126.81B 2.99B 2025-12
UCB EUR 18.16B 971M 2025-12